Cleared Traditional

K191738 - PageWriter TC20 Cardiograph

K191738 is the FDA 510(k) clearance for PageWriter TC20 Cardiograph by Philips Medical Systems. It is a Class 2 Cardiovascular device (product code DPS) cleared through the Traditional 510(k) pathway after a 459-day FDA review.

K191738 · Philips Medical Systems · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
459d
Days
Class 2
Risk

K191738 is an FDA 510(k) clearance for the PageWriter TC20 Cardiograph, PageWriter TC30 Cardiograph, PageWriter TC50 Car.... Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Philips Medical Systems (Shanghai, CN). The FDA issued a Cleared decision on September 29, 2020 after a review of 459 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Philips Medical Systems devices

Submission Details

510(k) Number K191738 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2019
Decision Date September 29, 2020
Days to Decision 459 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
334d slower than avg
Panel avg: 125d · This submission: 459d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 247
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K191738.
Page Writer TC20 Cardiograph, Page Writer TC30 Cardiograph, Page Writer TC50 Cardiograph, Page Writer TC70 Cardiograph
K210560 · Philips Medical Systems · Jun 2021
MAC 7 - Resting ECG Analysis System
K203786 · Ge Medical Systems Information Technologies, Inc. · Apr 2021
B-Secur HeartKey Software Library
K200884 · B-Secur , Ltd. · Dec 2020
physIQ Heart Rhythm and Respiration Module
K193415 · Physiq, Inc. · Jun 2020
AI-ECG Tracker
K200036 · Shenzhen Carewell Electronics Co., Ltd. · Mar 2020
CARDIOVIT AT-102 G2
K183425 · Schiller AG · Mar 2020